IMPORTANCE New treatment options are needed for patients with Lennox-Gastaut syndrome (LGS), a profoundly impairing, treatment-resistant, developmental and epileptic encephalopathy. OBJECTIVE To evaluate the efficacy and safety of fenfluramine in patients with LGS.

Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial / Kelly G Knupp , Ingrid E Scheffer , Berten Ceulemans , Joseph E Sullivan , Katherine C Nickels , Lieven Lagae , Renzo Guerrini , Sameer M Zuberi , Rima Nabbout, Kate Riney , Svetlana Shore , Anupam Agarwal , Michael Lock , Gail M Farfel , Bradley S Galer , Arnold R Gammaitoni , Ronald Davis , Antonio Gil-Nagel. - In: JAMA NEUROLOGY. - ISSN 2168-6149. - ELETTRONICO. - 79:(2022), pp. 554-564. [10.1001/jamaneurol.2022.0829]

Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial

Renzo Guerrini;
2022

Abstract

IMPORTANCE New treatment options are needed for patients with Lennox-Gastaut syndrome (LGS), a profoundly impairing, treatment-resistant, developmental and epileptic encephalopathy. OBJECTIVE To evaluate the efficacy and safety of fenfluramine in patients with LGS.
2022
79
554
564
Kelly G Knupp , Ingrid E Scheffer , Berten Ceulemans , Joseph E Sullivan , Katherine C Nickels , Lieven Lagae , Renzo Guerrini , Sameer M Zuberi , Rima Nabbout, Kate Riney , Svetlana Shore , Anupam Agarwal , Michael Lock , Gail M Farfel , Bradley S Galer , Arnold R Gammaitoni , Ronald Davis , Antonio Gil-Nagel
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1280972
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 11
social impact